MAX Surgical Specialty Management (MAX), a premier surgeon-led provider of oral and maxillofacial surgery (OMS), closed on a $77 million senior credit facility provided by Freeport Financial Partners. The financing will support the next phase of the company's strategic growth, with a focus on forming new partnerships with leading OMS practices across the Northeast.
"Staying close to the communities we serve is at the heart of our partnership strategy," said Mark Censoprano, Co-CEO of MAX. "This capital allows us to expand strategically throughout the region, building relationships where they matter most. Each new partnership reinforces our position as the premier OMS support platform in the Northeast."
In conjunction with the financing, MAX has partnered with Rothman and Kim Oral & Maxillofacial Surgery ("RKOMS"), a leading provider in the Philadelphia market with a second location in Cinnaminson, New Jersey. For over 25 years, Marc Rothman, DMD, M. David Kim, DMD, and their team have delivered exceptional patient care throughout the region. RKOMS marks MAX's second partnership in Pennsylvania.
The RKOMS partnership follows the recent addition of Oral and Maxillofacial Surgery of Westfield to MAX's network. Under the leadership of Ronen Gold, DDS, the practice has established a strong reputation in Westfield, New Jersey, for clinical excellence and a patient-first approach. This collaboration further strengthens MAX's growing network and solidifies its leadership position throughout New Jersey.
"MAX is assembling a network of elite oral and maxillofacial surgeons who share a vision of advancing excellence in patient care," said Dr. Jason M. Auerbach, Founder and Co-CEO of MAX. "Drs. Rothman, Kim and Gold have spent decades building outstanding reputations in their markets. With MAX's operational support and access to capital, they are now positioned to grow even further and continue leading innovation in the specialty."
Since January 2024, MAX has added 14 practice locations and 17 surgeons to its network across New Jersey, New York, Pennsylvania, Vermont and Connecticut. The company's total headcount has nearly doubled to over 300 in the last 15 months, driven by rapid expansion into new markets and investments in clinical and operational talent.
"This investment in MAX reflects deep confidence in the platform's outstanding performance, disciplined execution and leadership team," said Matt Gerdes, Managing Director of Freeport Financial Partners. "MAX's strong fundamentals and long-term value creation potential presented a compelling opportunity."
MAX's concentrated network of OMS practices in the Northeast offers strategic advantages in regional insights, established relationships and contracting leverage.